Raffa Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $1.89K | Sell |
5
-1
| -17% | -$349 | ﹤0.01% | 846 |
|
|
2026
Q2 | $1.76K | Buy |
6
+1
| +20% | +$284 | ﹤0.01% | 870 |
|
|
2026
Q1 | $1.39K | Hold |
5
| – | – | ﹤0.01% | 855 |
|
|
2025
Q4 | $1.52K | Hold |
5
| – | – | ﹤0.01% | 814 |
|
|
2025
Q3 | $1.4K | Sell |
5
-30
| -86% | -$8.16K | ﹤0.01% | 811 |
|
|
2025
Q2 | $8.45K | Buy |
35
+30
| +600% | +$7.09K | ﹤0.01% | 410 |
|
|
2025
Q1 | $1.22K | Hold |
5
| – | – | ﹤0.01% | 773 |
|
|
2024
Q4 | $1.64K | Hold |
5
| – | – | ﹤0.01% | 723 |
|
|
2024
Q3 | $1.67K | Hold |
5
| – | – | ﹤0.01% | 685 |
|
|
2024
Q2 | $1.37K | Hold |
5
| – | – | ﹤0.01% | 812 |
|
|
2024
Q1 | $1.73K | Hold |
5
| – | – | ﹤0.01% | 743 |
|
|
2023
Q4 | $1.61K | Hold |
5
| – | – | ﹤0.01% | 685 |
|
|
2023
Q3 | $1.79K | Hold |
5
| – | – | ﹤0.01% | 618 |
|
|
2023
Q2 | $1.9K | Hold |
5
| – | – | ﹤0.01% | 621 |
|
|
2023
Q1 | $2.4K | Hold |
5
| – | – | ﹤0.01% | 557 |
|
|
2022
Q4 | $2.1K | Hold |
5
| – | – | ﹤0.01% | 574 |
|
|
2022
Q3 | $2.09K | Hold |
5
| – | – | ﹤0.01% | 586 |
|
|
2022
Q2 | $2.48K | Hold |
5
| – | – | ﹤0.01% | 553 |
|
|
2022
Q1 | $2.82K | Hold |
5
| – | – | ﹤0.01% | 546 |
|
|
2021
Q4 | $3.78K | Hold |
5
| – | – | ﹤0.01% | 497 |
|
|
2021
Q3 | $3.73K | Hold |
5
| – | – | ﹤0.01% | 451 |
|
|
2021
Q2 | $3.22K | Hold |
5
| – | – | ﹤0.01% | 490 |
|
|
2021
Q1 | $2.86K | Buy |
5
+1
| +25% | +$592 | ﹤0.01% | 539 |
|
|
2020
Q4 | $2.33K | Hold |
4
| – | – | ﹤0.01% | 517 |
|
|
2020
Q3 | $2.06K | Hold |
4
| – | – | ﹤0.01% | 489 |
|
|
2020
Q2 | $1.81K | Hold |
4
| – | – | ﹤0.01% | 498 |
|
|
2020
Q1 | $1.4K | Hold |
4
| – | – | ﹤0.01% | 498 |
|
|
2019
Q4 | $1.48K | Hold |
4
| – | – | ﹤0.01% | 477 |
|
|
2019
Q3 | $1.33K | Buy |
+4
| New | +$1.3K | ﹤0.01% | 494 |
|
|
2019
Q2 | – | Sell |
-4
| Closed | -$1.22K | – | 815 |
|
|
2019
Q1 | $1.22K | Hold |
4
| – | – | ﹤0.01% | 487 |
|
|
2018
Q4 | $929 | Hold |
4
| – | – | ﹤0.01% | 566 |
|
|
2018
Q3 | $1.25K | Hold |
4
| – | – | ﹤0.01% | 508 |
|
|
2018
Q2 | $1.15K | Hold |
4
| – | – | ﹤0.01% | 517 |
|
|
2018
Q1 | $1K | Buy |
+4
| New | +$1.02K | ﹤0.01% | 552 |
|
Other funds holding BIO
Raffa Wealth Management's BIO Position: Q3 2026 in Review
Raffa Wealth Management reduced its Bio-Rad Laboratories Class A (BIO) stake by 17% in Q3 2026, selling an estimated $349 and leaving 5 shares worth $1.89K. The position accounts for ﹤0.01% of the portfolio, ranked #846.
Raffa Wealth Management first reported a position in BIO in Q1 2018 and has held it in 34 quarters since. The position peaked at $8.45K in Q2 2025. 417 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Raffa Wealth Management held 5 shares of Bio-Rad Laboratories Class A worth $1.89K as of Q3 2026.
- Raffa Wealth Management sold 1 Bio-Rad Laboratories Class A share in Q3 2026, an estimated $349.
- Bio-Rad Laboratories Class A made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #846 holding.
- Raffa Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q1 2018 and has held it in 34 quarters since.
- Raffa Wealth Management's Bio-Rad Laboratories Class A position peaked at $8.45K in Q2 2025.
- 417 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.